SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-22-000484
Filing Date
2022-03-23
Accepted
2022-03-23 17:30:38
Documents
1
Period of Report
2022-03-21

Document Format Files

Seq Description Document Type Size
1 jasper_fm4mar212022.html 4  
1 jasper_fm4mar212022.xml 4 6107
  Complete submission text file 0000905718-22-000484.txt   7740
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Reporting) CIK: 0001397144 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-39138 | Film No.: 22764009

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)